![Featured Image](https://vumc-reporter.s3.amazonaws.com/uploads/reporter_33007_5.jpg)
Raymond DuBois, M.D., Ph.D.
For third time, a VICC leader will head cancer research association
Raymond DuBois, M.D., Ph.D., former director of the Vanderbilt-Ingram Cancer Center, has been nominated president-elect of the American Association for Cancer Research (AACR).
“The AACR is at a critical stage in its evolution as it prepares to celebrate 100 years of progress in the fight against cancer,” said DuBois.
“By supporting cancer research from the basic science laboratory all the way to late phase clinical trials, the AACR has taken on the crucial mission of supporting work that will ultimately decrease morbidity and mortality from cancer.”
DuBois recently stepped down as director of Vanderbilt-Ingram in anticipation of his new role as provost and executive vice president for academic affairs at the University of Texas M. D. Anderson Cancer Center in Houston.
DuBois is a Texas native and received his M.D. at The University of Texas Health Science Center in San Antonio and his Ph.D. at The University of Texas Health Science Center in Dallas.
His role in the AACR marks the third time a Vanderbilt-Ingram leader has served as president of the organization. Lynn Matrisian, Ph.D., director of Cancer Biology, and Harold Moses, M.D., director emeritus of Vanderbilt-Ingram, were both elected AACR president in recent years.
DuBois succeeds William Hait, M.D., Ph.D., head of Worldwide Oncology Research and Development at Johnson & Johnson, who will become president of the AACR. Geoffrey Wahl, Ph.D., of The Salk Institute for Biological Sciences in La Jolla, Calif., who has served as AACR president for the 2006-2007 term, will fulfill the role of past president.
The positions take effect April 16 at the AACR Annual Meeting in Los Angeles. The president, president-elect and past president serve terms of one year, comprising the period between annual meetings.